BioAegis says its 'inflammation regulator' is best weapon to fight Covid-19
May 11, 2020 at 10:23 AM EDT
BioAegis Therapeutics is currently awaiting FDA approval to begin testing its plasma gelsolin therapy on Covid-19 patients. The company says its treatment prevents the damage caused by excess inflammation without suppressing the immune system and offers the best defense against the virus.